Good Health is Your Greatest Wealth……Virgil
| In the past few weeks, the Food and Drug Administration has given its blessing to both pills, Belviq and Qsymia, the first new weight–loss drugs to win approval since 1999. To Fitch, an obesity specialist at Park Nicollet Clinic, that's reason to … See all stories on this topic » |
 Minneapolis Star Tribune |
| But most diet pills haven't been approved for safe weight loss by the Food and Drug Administration, and products often make unsubstantiated scientific claims, consumer experts say. Also, dietary supplements don't need to register with the FDA nor … See all stories on this topic » |
 USA TODAY |
Within the past month, the U.S. Food and Drug Administration approved two weight–loss drugs, the first such drugs to be approved by the administration in more than a decade. But neither are standalone treatments, said JoeBob Kirk, a bariatric physician …
See all stories on this topic »
TUESDAY, July 24 (HealthDay News) — The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) in people 18 and older.
TEL AVIV (Reuters) – Pluristem Therapeutics Inc will apply to the U.S. Food and Drug Administration for approval of its placenta-based stem cell treatment for aplastic bone marrow as an orphan drug or rare disease treatment, it said on Monday. Gaining orphan drug status is part of Pluristem’s strategy for penetrating the bone marrow recovery market, starting with treatment of aplastic anaemia, a disease that affects five to 10 people in every million. …
The U.S. Food and Drug Administration today approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management. The drug is approved for use in adults with a body mass index …
See all stories on this topic »
A second weight loss pill has been approved by the Food and Drug Administration in two months. The drug named Qsymia is … to control and reduce weight. Dr. Tim Garvey from the University of Alabama, Birmingham, thinks that relatively better …
See all stories on this topic »
WASHINGTON (Reuters) – U.S. drug regulators approved Onyx Pharmaceuticals Inc’s Kyprolis for people with a type of blood cancer that has failed to respond to other medicines. The U.S. Food and Drug Administration said on Friday the intravenous drug was approved for treating multiple myeloma in people who have tried at least two other medicines, including Takeda Pharmaceutical Co Ltd’s Velcade and Celgene Corp’s Revlimid or Thalomid. Multiple myeloma, a type of cancer that affects the plasma cells in bone marrow, is relatively rare in the United States but often deadly. …
(Reuters) – The U.S. Food and Drug Administration on Friday approved Novartis AG drug Afinitor to treat women with a certain type of breast cancer. The drug is the first in a class known as mTOR inhibitors to be approved for post-menopausal women with advanced hormone-receptor positive, HER2-negative breast cancer. The European Medicines Agency in June also endorsed Afinitor as a breast cancer treatment. …
FRIDAY, July 20 (HealthDay News) — Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.
FRIDAY, July 20 (HealthDay News) — The U.S. Food and Drug Administration on Friday approved the use of the drug Afinitor (everolimus) for use by women with a particular form of advanced breast cancer.
FRIDAY, July 20 (HealthDay News) — Afinitor (everolimus) has been approved in combination with the drug exemestane to treat postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer, the U.S. Food and Drug Administration said Friday.